ESR1 and breast cancer: A recent study revealed that inhibition of piR-823 increased ER-α expression while decreasing the expression of human telomerase reverse transcriptase (hTERT) and the phosphatidylinositol 3-kinase (PI3K)/AKT/mTOR pathway, which influences cell proliferation and cellular properties in triple-negative BC cells (oner 2022).